Skip to main content
. 2023 Jul 3;15(7):3593–3604. doi: 10.21037/jtd-23-37

Table 3. Comparison of demographics, preoperative clinical and oncological characteristics among the Transhiatal and McKeown esophagectomy group.

Variables No leak (N=556) Leak (N=95) P value
Age (years) 66.00 (58.00–71.00) 65.00 (58.00–71.00) 0.937
Male gender 470 (84.53) 76 (80.00) 0.267
BMI (kg/m2) 26.92 (23.86–30.45) 27.24 (24.63–32.14) 0.203
Pre-operative serum creatinine 0.83 (0.70–0.98) 0.87 (0.70–1.10) 0.260
Pre-operative serum albumin 3.80 (3.50–4.10) 3.90 (3.50–4.20) 0.900
Diabetes 26 (4.68) 16 (16.84) <.001
Smoking (within one year) 131 (23.56) 25 (26.32) 0.561
COPD 39 (7.01) 10 (10.53) 0.231
CHF (30 days before surgery) 3 (0.54) 0 (0.00) 0.473
Hypertension (on medications) 268 (48.20) 50 (52.63) 0.425
Weight loss (>10% last 6 months) 117 (21.04) 20 (21.05) 0.998
Steroid use for chronic condition 17 (3.06) 2 (2.11) 0.610
ASA classification 0.233
   ASA Class 1 & 2 91 (16.40) 11 (11.58)
   ASA Class 3 & 4 464 (83.60) 84 (88.42)
Total operative time (minutes) 302.00 (228.50–420.00) 370.00 (243.00–445.00) 0.020
Surgeon specialty 0.426
   Thoracic surgery 223 (40.11) 34 (35.79)
   General surgery 333 (59.89) 61 (64.21)
T (tumor) stage 0.426
   T0/Tis 63 (12.19) 14 (15.73)
   T1 165 (31.91) 25 (28.09)
   T2 88 (17.02) 20 (22.47)
   T3 195 (37.72) 28 (31.46)
   T4 6 (1.16) 2 (2.25)
N (node) stage 0.520
   N0 323 (61.17) 48 (53.93)
   N1 114 (21.59) 24 (26.97)
   N2 61 (11.55) 10 (11.24)
   N3 30 (5.68) 7 (7.87)
Pathology 0.378
Adenocarcinoma 457 (82.34) 82 (88.17)
Squamous cell 73 (13.15) 8 (8.60)
Other malignancy 25 (4.50) 3 (8.60)
Perioperative chemotherapy 384 (69.69) 64 (68.09) 0.755
Perioperative radiotherapy 343 (62.25) 58 (61.70) 0.919

Continuous variables are presented as mean ± SD and categorical variables as number (percentage)., within 90 days of surgery. BMI, body mass index; COPD, chronic obstructive pulmonary disease; CHF, congestive heart failure; ASA, American Society of Anesthesiologists; SD, standard deviation.